Author | Tanya Siddiqi, MD | OncLive

Author | Tanya Siddiqi, MD

Articles

Dr. Siddiqi on the Results of the TRANSCEND CLL 004 Trial in CLL

February 11, 2020

Video

Tanya Siddiqi, MD, discusses the results of the TRANSCEND CLL 004 trial.

Dr. Siddiqi on Rationale for the TRANSCEND CLL 004 Trial in CLL/SLL

October 23, 2019

Video

Tanya Siddiqi, MD, discusses the rationale for the phase I/II TRANSCEND CLL 004 trial investigating the use of the CAR T-cell therapy lisocabtagene maraleucel in patients with relapsed/refractory chronic lymphocytic leukemia or small lymphocytic lymphoma.

Dr. Siddiqi on the Safety Profile of Liso-Cel in the TRANSCEND CLL 004 Trial

September 13, 2019

Video

Tanya Siddiqi, MD, a hematologist/oncologist at City of Hope, discusses the safety profile of lisocabtagene maraleucel (liso-cel; JCAR017) in the TRANSCEND CLL 004 trial.

Dr. Siddiqi on the CLL14 Trial Results in CLL

August 03, 2019

Video

Tanya Siddiqi, MD, a hematologist/oncologist at City of Hope, discusses the CLL14 trial, which tested venetoclax (Venclexta) plus obinutuzumab (Gazyva) versus obinutuzumab plus chlorambucil in patients with previously untreated chronic lymphocytic leukemia and coexisting conditions.

x